Menu
Back to Journals » Vascular Health and Risk Management » Volume 16
Review
Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,031 | Dovepress* | 5,124+ | 1,301 | 6,425 | |
| PubMed Central* | 907 | 312 | 1,219 | ||
| Totals | 6,031 | 1,613 | 7,644 | ||
| *Since 7 October 2020 | |||||
View citations on PubMed Central and Google Scholar